Literature DB >> 28001176

Hyperuricemia as a potential risk factor for type 2 diabetes and diabetic nephropathy.

Pratik Shah1, Petter Bjornstad2, Richard J Johnson1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 28001176     DOI： 10.5935/0101-2800.20160061

Source DB:  PubMed          Journal:  J Bras Nefrol        ISSN： 0101-2800


× No keyword cloud information.
  9 in total

1.  Study on Risk Factors of Diabetic Nephropathy in Obese Patients with Type 2 Diabetes Mellitus.

Authors:  Fan Hu; Taotao Zhang
Journal:  Int J Gen Med       Date:  2020-07-06

2.  Uric acid-lowering and renoprotective effects of topiroxostat, a selective xanthine oxidoreductase inhibitor, in patients with diabetic nephropathy and hyperuricemia: a randomized, double-blind, placebo-controlled, parallel-group study (UPWARD study).

Authors:  Takashi Wada; Tatsuo Hosoya; Daisuke Honda; Ryusuke Sakamoto; Kazutaka Narita; Tomomitsu Sasaki; Daisuke Okui; Kenjiro Kimura
Journal:  Clin Exp Nephrol       Date:  2018-01-25       Impact factor: 2.801

3.  Association of eating out frequency and other factors with serum uric acid levels and hyperuricemia in Chinese population.

Authors:  Ningning Cui; Xiaokang Dong; Wei Liao; Yuan Xue; Xiaotian Liu; Xing Li; Jian Hou; Wenqian Huo; Linlin Li; Zhenxing Mao; Chongjian Wang; Yuqian Li
Journal:  Eur J Nutr       Date:  2021-07-23       Impact factor: 5.614

4.  Prevalence and Determinants of Hyperuricemia in Type 2 Diabetes Mellitus Patients Attending Jimma Medical Center, Southwestern Ethiopia, 2019.

Authors:  Kumsa Kene Arersa; Tesaka Wondimnew; Mengistu Welde; Tigist Mateos Husen
Journal:  Diabetes Metab Syndr Obes       Date:  2020-06-18       Impact factor: 3.168

5.  Relationship between oxidative stress and inflammation in hyperuricemia: Analysis based on asymptomatic young patients with primary hyperuricemia.

Authors:  You Zhou; Mingcai Zhao; Zheyan Pu; Guoqiang Xu; Xiangkun Li
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

6.  Hyperuricemia and its Association with Cardiovascular Disease Risk Factors in Type Two Diabetes Mellitus Patients at the University of Gondar Hospital, Northwest Ethiopia.

Authors:  Birhanu Woldeamlak; Ketsela Yirdaw; Belete Biadgo
Journal:  EJIFCC       Date:  2019-10-11

7.  Associations of serum uric acid level with diabetic retinopathy and albuminuria in patients with type 2 diabetes mellitus.

Authors:  Lin Hou; Yingzhou Shi; Sichao Wang; Qing Chen; Qiu Li; Meng Zhao; Xinli Zhou
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

8.  Carvacrol Alleviates Hyperuricemia-Induced Oxidative Stress and Inflammation by Modulating the NLRP3/NF-κB Pathwayt.

Authors:  Muhammad Riaz; Lina Tariq Al Kury; Noreen Atzaz; Abdullah Alattar; Reem Alshaman; Fawad Ali Shah; Shupeng Li
Journal:  Drug Des Devel Ther       Date:  2022-04-22       Impact factor: 4.319

9.  Hyperuricemia in type 2 diabetic model KK-Ay/Ta mice: a potent animal model with positive correlation between insulin resistance and plasma high uric acid levels.

Authors:  Shin-Ichi Adachi; Fumiaki Yoshizawa; Kazumi Yagasaki
Journal:  BMC Res Notes       Date:  2017-11-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.